Skip to main content

Randomized Phase 2 (Ph2) clinical trial of Lerapolturev (previously known as PVSRIPO) in recurrent glioblastoma (rGBM)

Clinical Trial Grant
Duke Scholars

Administered By

Neurosurgery, Neuro-Oncology

Awarded By

Brain Tumor Research Charity

Start Date

May 1, 2024

End Date

April 30, 2027
 

Administered By

Neurosurgery, Neuro-Oncology

Awarded By

Brain Tumor Research Charity

Start Date

May 1, 2024

End Date

April 30, 2027